Skip to main content

Al was diagnosed with Ph+ CML in chronic phase in 1997, before the first tyrosine kinase inhibitor (TKI) was available to treat the disease. He provides insights about being open to discussing the use of different medications with your doctor if you are not meeting your treatment goals or if side effects are becoming intolerable.

Please note, Al cannot provide clinical advice or counseling. For medical questions, speak with your doctor.

Al is an actual patient who has been compensated by Novartis Pharmaceuticals Corporation for participating in the SCEMBLIX Peers program.


Watch videos of Al's answers

Would you say CML is a “good cancer?”

What results have you seen with SCEMBLIX?

What is SCEMBLIX and what are the possible side effects?

Get the perspective of another SCEMBLIX Peer.


Hear about Lynne's Experience

Lynne's Experience

Important Safety Information

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

  • have a history of inflammation of your pancreas (pancreatitis)
  • have a history of heart problems or blood clots in your arteries and veins (types of blood vessels)
  • are pregnant or plan to become pregnant. SCEMBLIX can harm your unborn baby ...

Approved Uses

SCEMBLIX is a prescription medicine used to treat adults with:

  • Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitors (TKIs)
  • Ph+ CML in CP with the T315I mutation ...